Company Filing History:
Years Active: 1993
Title: Subramani N Iver: Innovator in Pharmaceutical Chemistry
Introduction
Subramani N Iver is a notable inventor based in Bombay, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic use. His work focuses on creating effective treatments for protozoal infections.
Latest Patents
Subramani N Iver holds a patent for "10-substituted ether derivatives of dihydroartemisinin, process for - 10-substituted ether derivatives of 3.alpha., 12.alpha.-Epoxy-3,4,5 5a.alpha., 6,7,8,8a.alpha.,9,10,12.beta., 12a-dodecahydro-10-hydroxy-3.beta.,6.alpha.,9.beta.-trimethylpyano-(4,3-j) (1,2) benzodioxepin." This patent, also known as Dihydroartemisinin or Dihydroquinghaosu (DHQ), includes pharmaceutically acceptable salts, processes for their preparation, and their use as chemotherapeutics against protozoal infections. He has 1 patent to his name.
Career Highlights
Subramani N Iver is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has contributed to advancements in drug development and has the potential to impact the treatment of various diseases.
Collaborations
He has collaborated with notable colleagues such as Bindumadhavan Venugopalan and Chintamani P Bapat, enhancing the scope and impact of his research.
Conclusion
Subramani N Iver's innovative work in pharmaceutical chemistry exemplifies the importance of research and development in creating effective treatments for health challenges. His contributions continue to influence the field and pave the way for future advancements.